Effectiveness and safety of first‐line tenofovir + emtricitabine + efavirenz for patients with HIV

Reason for withdrawal from publication Temporarily withdrawn so that the authors may add some studies that were apparently missed. To view the published versions of this article, please click the 'Other versions' tab.